BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26796737)

  • 21. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
    Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
    Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
    Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
    Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?
    Zidi I; Kharrat N; Sebai R; Zidi N; Ben Yahia H; Bouaziz A; Rifi H; Mezlini A; Rizzo R
    Immunol Res; 2016 Apr; 64(2):636-9. PubMed ID: 26663018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
    Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
    Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.
    Sayed D; Badr G; Maximous D; Mikhail NN; Abu-Tarboush F; Alhazza IM
    Tissue Antigens; 2010 Jan; 75(1):40-7. PubMed ID: 20196818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.
    Nardi Fda S; König L; Wagner B; Giebel B; Santos Manvailer LF; Rebmann V
    HLA; 2016 Sep; 88(3):77-86. PubMed ID: 27440734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients.
    Jeong S; Park S; Park BW; Park Y; Kwon OJ; Kim HS
    PLoS One; 2014; 9(5):e98284. PubMed ID: 24870375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
    Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
    Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
    Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
    Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term.
    Klitkou L; Dahl M; Hviid TV; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Christiansen OB
    Hum Immunol; 2015 Apr; 76(4):254-9. PubMed ID: 25636573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
    Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer.
    Li JB; Ruan YY; Hu B; Dong SS; Bi TN; Lin A; Yan WH
    Oncotarget; 2017 Jul; 8(30):48854-48862. PubMed ID: 28415627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
    Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
    Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-G is a potential tumor marker in malignant ascites.
    Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
    Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
    Alsahebfosoul F; Zavaran Hosseini A; Salehi R; Etemadifar M; Esmaeil N; Jamshidian A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):298-305. PubMed ID: 26546899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients.
    Zidi I; Laaribi AB; Bortolotti D; Belhadj M; Mehri A; Yahia HB; Babay W; Chaouch H; Zidi N; Letaief A; Yacoub S; Boukadida J; Di Luca D; Hannachi N; Rizzo R
    HLA; 2016 Mar; 87(3):153-9. PubMed ID: 26956431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.
    Rizzo R; Pietrobon S; Mazzoni E; Bortolotti D; Martini F; Castellazzi M; Casetta I; Fainardi E; Di Luca D; Granieri E; Tognon M;
    J Transl Med; 2016 Jul; 14(1):216. PubMed ID: 27443345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
    Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
    Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.